This episode covers MidJourney’s surprising pivot to hardware with a full-body ultrasound scanner and the marketing boost from Anthropic’s federal ban. It also discusses Amazon MGM dropping the Sam Altman film "Artificial" and AWS selling Trainium chips externally to compete with NVIDIA. Finally, the host analyzes Intel’s stock surge following a new chip design deal with Apple.